Assessment of chemical modifications of sites in the CDRs of recombinant antibodies
Markus Haberger,Katrin Bomans,Katharina Diepold,Michaela Hook,Jana Gassner,Tilman Schlothauer,Adrian Zwick,Christian Spick,Jochen Felix Kepert,Brigitte Hienz,Michael Wiedmann,Hermann Beck,Philipp Metzger,Michael Mølhøj,Constanze Knoblich,Ulla Grauschopf,Dietmar Reusch,Patrick Bulau
DOI: https://doi.org/10.4161/mabs.27876
2014-01-17
mAbs
Abstract:Modifications like asparagine deamidation, aspartate isomerization, methionine oxidation, and lysine glycation are typical degradations for recombinant antibodies. For the identification and functional evaluation of antibody critical quality attributes (CQAs) derived from chemical modifications in the complementary-determining regions (CDRs) and the conserved regions, an approach employing specific stress conditions, elevated temperatures, pH, oxidizing agents, and forced glycation with glucose incubation, was applied. The application of the specific stress conditions combined with ion exchange chromatography, proteolytic peptide mapping, quantitative liquid chromatography mass spectrometry, and functional evaluation by surface plasmon resonance analysis was adequate to identify and functionally assess chemical modification sites in the CDRs of a recombinant IgG1. LC-Met-4, LC-Asn-30/31, LC-Asn-92, HC-Met-100c, and HC Lys-33 were identified as potential CQAs. However, none of the assessed degradation products led to a complete loss of functionality if only one light or heavy chain of the native antibody was affected.
medicine, research & experimental